
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
Junshang Ge, Jie Wang, Hui Wang, et al.
Journal of Cancer (2019) Vol. 11, Iss. 4, pp. 932-939
Open Access | Times Cited: 57
Junshang Ge, Jie Wang, Hui Wang, et al.
Journal of Cancer (2019) Vol. 11, Iss. 4, pp. 932-939
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
Pan Wu, Yongzhen Mo, Peng Miao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 466
Pan Wu, Yongzhen Mo, Peng Miao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 466
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Daixi Ren, Yuze Hua, Boyao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 249
Daixi Ren, Yuze Hua, Boyao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 249
Single‐cell RNA sequencing in cancer research
Yijie Zhang, Dan Wang, Peng Miao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 249
Yijie Zhang, Dan Wang, Peng Miao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 249
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
Fang Wei, Dan Wang, Junyuan Wei, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 1, pp. 173-193
Closed Access | Times Cited: 94
Fang Wei, Dan Wang, Junyuan Wei, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 1, pp. 173-193
Closed Access | Times Cited: 94
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
Yujia Liu, Jiafeng Wang, Xiao Hu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100939-100939
Open Access | Times Cited: 33
Yujia Liu, Jiafeng Wang, Xiao Hu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100939-100939
Open Access | Times Cited: 33
Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy
Chunmei Fan, Shanshan Zhang, Zhaojian Gong, et al.
Science China Life Sciences (2020) Vol. 64, Iss. 4, pp. 534-547
Closed Access | Times Cited: 66
Chunmei Fan, Shanshan Zhang, Zhaojian Gong, et al.
Science China Life Sciences (2020) Vol. 64, Iss. 4, pp. 534-547
Closed Access | Times Cited: 66
LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma
Ting Tang, Liting Yang, Yujian Cao, et al.
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 2251-2270
Open Access | Times Cited: 59
Ting Tang, Liting Yang, Yujian Cao, et al.
Molecular Oncology (2020) Vol. 14, Iss. 9, pp. 2251-2270
Open Access | Times Cited: 59
N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies
Fenghua Tan, Mengyao Zhao, Fang Xiong, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 42
Fenghua Tan, Mengyao Zhao, Fang Xiong, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 42
Abnormal X chromosome inactivation and tumor development
Dan Wang, Le Tang, Yingfen Wu, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 15, pp. 2949-2958
Closed Access | Times Cited: 44
Dan Wang, Le Tang, Yingfen Wu, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 15, pp. 2949-2958
Closed Access | Times Cited: 44
Epstein‐Barr virus‐encoded miR‐BART6‐3p inhibits cancer cell proliferation through the LOC553103‐STMN1 axis
Dan Wang, Zhaoyang Zeng, Shanshan Zhang, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8012-8027
Closed Access | Times Cited: 42
Dan Wang, Zhaoyang Zeng, Shanshan Zhang, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8012-8027
Closed Access | Times Cited: 42
The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta‐analysis
Bojie Chen, Yuan Shi, Yanan Xu, et al.
Clinical Endocrinology (2020) Vol. 94, Iss. 5, pp. 731-742
Open Access | Times Cited: 42
Bojie Chen, Yuan Shi, Yanan Xu, et al.
Clinical Endocrinology (2020) Vol. 94, Iss. 5, pp. 731-742
Open Access | Times Cited: 42
Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis
Bo Song, Zheyu Lin, Chuyao Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Bo Song, Zheyu Lin, Chuyao Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors
Kang Wen, Xin Chen, Jingyao Gu, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Kang Wen, Xin Chen, Jingyao Gu, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers
Chunmei Fan, Jinpeng Wang, Yanyan Tang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Chunmei Fan, Jinpeng Wang, Yanyan Tang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis
Yang Liu, Ting‐Yu Chen, Zhi-Yan Yang, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 29
Yang Liu, Ting‐Yu Chen, Zhi-Yan Yang, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 29
Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN Stage
Zhihong Wang, Peng Tang, Surong Hua, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 147-157
Open Access | Times Cited: 17
Zhihong Wang, Peng Tang, Surong Hua, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 147-157
Open Access | Times Cited: 17
BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases
David Kalfeřt, Marie Ludvíková, Martin Pešta, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155319-155319
Closed Access | Times Cited: 3
David Kalfeřt, Marie Ludvíková, Martin Pešta, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155319-155319
Closed Access | Times Cited: 3
Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
Kirk Jensen, Shilpa Thakur, Aneeta Patel, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2481-2481
Open Access | Times Cited: 27
Kirk Jensen, Shilpa Thakur, Aneeta Patel, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2481-2481
Open Access | Times Cited: 27
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
Hamid Aria, Marzieh Rezaei, Shima Nazem, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Hamid Aria, Marzieh Rezaei, Shima Nazem, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway.
Luyuan Zhang, Sinan Sun, Yumin Wang, et al.
PubMed (2020) Vol. 10, Iss. 3, pp. 870-883
Closed Access | Times Cited: 23
Luyuan Zhang, Sinan Sun, Yumin Wang, et al.
PubMed (2020) Vol. 10, Iss. 3, pp. 870-883
Closed Access | Times Cited: 23
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis
Huili Pan, Zhiyan Luo, Lin Feng, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
Huili Pan, Zhiyan Luo, Lin Feng, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
AFAP1-AS1: a rising star among oncogenic long non-coding RNAs
Fang Xiong, Kunjie Zhu, Su Deng, et al.
Science China Life Sciences (2021) Vol. 64, Iss. 10, pp. 1602-1611
Open Access | Times Cited: 17
Fang Xiong, Kunjie Zhu, Su Deng, et al.
Science China Life Sciences (2021) Vol. 64, Iss. 10, pp. 1602-1611
Open Access | Times Cited: 17
Comparison of diagnostic value of SWE, FNA and BRAF gene detection in ACR TI-RADS 4 and 5 thyroid nodules
Weibing Zhang, Wen-Fang Deng, Lun Mao, et al.
Clinical Hemorheology and Microcirculation (2022) Vol. 81, Iss. 1, pp. 13-21
Closed Access | Times Cited: 12
Weibing Zhang, Wen-Fang Deng, Lun Mao, et al.
Clinical Hemorheology and Microcirculation (2022) Vol. 81, Iss. 1, pp. 13-21
Closed Access | Times Cited: 12
Screening of ferroptosis-related genes in sepsis-induced liver failure and analysis of immune correlation
Qingli Chen, Luxiang Liu, Shuangling Ni
PeerJ (2022) Vol. 10, pp. e13757-e13757
Open Access | Times Cited: 12
Qingli Chen, Luxiang Liu, Shuangling Ni
PeerJ (2022) Vol. 10, pp. e13757-e13757
Open Access | Times Cited: 12